Most overnight AHA treatments follow a predictable formula: take a well-studied acid, put it in a gel, tell people to use sunscreen. Bioderma's Sebium Night Peel starts there, then asks a more interesting question — what if the problem isn't just dead skin sitting in pores, but the sebum itself going rancid?
That question is the foundation of Bioderma's Fluidactiv patent, and it's what makes this product worth discussing beyond its headline ingredient. Yes, there's 15% glycolic acid here, and it does exactly what you'd expect — dissolves the intercellular cement holding dead corneocytes together, accelerates turnover, brightens the complexion over a four-week cycle. Glycolic acid is the most studied AHA in dermatology, with decades of clinical trials confirming its efficacy for comedonal acne, texture improvement, and mild hyperpigmentation. At 15%, this sits in a productive middle ground: stronger than the 5-10% formulas lining drugstore shelves, gentler than the 30-70% peels applied by aestheticians in controlled settings.
The number on the front is also less alarming than it looks, and understanding why matters. Sodium hydroxide sits second in the INCI, partially neutralizing the acid and bringing the finished gel to a pH of 3.8 — which puts the free acid, the fraction actually doing the exfoliating, somewhere in the 5-8% range. That is why a "15% glycolic" product can be applied nightly for a month without stripping your face off. The rest of the glycolic is present as its salt, contributing more slowly and more gently.
But the formulation strategy here goes deeper than acid strength. Bioderma's NAOS Research team identified that in acne-prone skin, squalene — a natural component of sebum — undergoes oxidation, becoming comedogenic and pro-inflammatory. The Fluidactiv complex, built from mannitol, xylitol, rhamnose, fructooligosaccharides, and laminaria ochroleuca extract, targets this oxidation process. It's a biological intervention running alongside the chemical exfoliation, addressing a root cause that most peel products don't even acknowledge. Propyl gallate and sodium metabisulfite sit nearby as antioxidants, protecting the formula and reinforcing the same anti-oxidation logic.
The prebiotic angle deserves attention too. Fructooligosaccharides selectively feed beneficial Staphylococcus epidermidis while the glycolic acid reshapes the skin surface — a thoughtful hedge against the microbiome disruption that high-concentration acids can cause. It's the kind of formulation detail that reveals a research team thinking about skin as an ecosystem rather than a surface to strip and rebuild.
The actual experience of using this product is less glamorous than its science. The clear gel applies easily and absorbs fast, but dries to a noticeable tackiness that can transfer to pillowcases. It's the sort of cosmetic inconvenience that separates pharmacy-developed products from consumer-first brands — the NAOS team clearly prioritized formula integrity over sensory elegance. You'll feel a mild tingle on application, especially during the first few nights, but it's well within the range of tolerable. Credit the panthenol here, present at an estimated 2.6-3.9% — high enough to meaningfully reduce transepidermal water loss and soothe the acid-treated skin overnight.
The protocol is not negotiable and it is where most people go wrong. This goes on clean, dry skin as the last thing you do at night — nothing over it, nothing under it. No retinoid, no vitamin C, no second acid, no benzoyl peroxide sharing the same evening. And sunscreen the next morning is a condition of use, not a suggestion; freshly exfoliated skin that meets UV unprotected trades a smoother texture for a darker one.
The cycling protocol sets this apart from typical daily-use exfoliants. Bioderma prescribes four weeks of nightly use followed by a full month off, repeating the cycle up to four times per year. It's a clinical rhythm rather than a consumer-friendly daily habit, and it demands some discipline. But there's logic behind it: continuous use of 15% glycolic acid risks chronic barrier compromise and tolerance development, while the rest period allows full recovery and ensures each new cycle hits with full efficacy.
Results follow a predictable arc. The first week may bring purging — small breakouts as subsurface congestion is pushed up by accelerated turnover. By week two, texture smoothing becomes visible. By the end of the four-week cycle, users consistently report clearer skin, reduced blemish frequency, and fading of post-inflammatory dark marks. What this product doesn't do particularly well is address deep pitted scarring or significantly shrink pores — those expectations are beyond what any topical AHA can deliver, and the several hundred reviews that mention disappointment on that front are mostly disappointed with the category rather than the product.
The ingredient list is refreshingly short for a product this effective. Sixteen ingredients total, no silicones, no oils, no unnecessary thickeners. But there's an asterisk: fragrance. In a formula built around a high-concentration acid — one that increases skin permeability and sensitivity — the inclusion of parfum feels like a concession to the consumer experience that contradicts the otherwise clinical formulation philosophy. It's Bioderma's most notable misstep here. Dry and sensitive skin should stay away regardless, and it is not a fungal-acne-safe formula.
At roughly $27 for 40 ml, this isn't cheap for what amounts to a gel in a small pump bottle. But the concentration of glycolic acid, the supporting actives, and the patent-backed technology make this more than a simple AHA product. Each bottle covers a full four-week treatment cycle, and with the month-off rest period, your annual spend works out to around $80-$100 — reasonable for a treatment-grade product. The limited US availability means you may need to order from international pharmacies, which adds shipping costs and wait times.
This is a product for people who appreciate formulation intelligence over packaging aesthetics, who are willing to follow a structured protocol rather than slap on another serum, and whose oily or combination skin needs intervention beyond what daily-use acids provide. It's not trying to be everything to everyone — and it's better for that focus.
